Stempeutics Research receives patent for critical limb ischemia treatment method

"The US patent is for the method of treating ischemia by administering pooled allogeneic mesenchymal stromal cells," Stempeutics Research said in a statement. Critical Limb Ischemia is a severe blockage in the arteries which results in reduced blood flow which in turn may result in poor quality of life.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news